What can we learn from individual- level studies of antibiotic resistance? Molly Franke EPI 502 January 17, 2008.

Slides:



Advertisements
Similar presentations
Hospital-acquired and community-acquired MRSA in hospitals
Advertisements

NOSOCOMIAL ANTIBIOTIC RESISTANT ORGANISMS
Mathematical Modelling of Healthcare Associated Infections Theo Kypraios Division of Statistics, School of Mathematical Sciences
Louise Giovannone, Patty Flanagan, Elizabeth Haver-Browne.
Comparator Selection in Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research and Quality (AHRQ)
ARE CAP AND HCAP TWO SEPARATE ENTITIES? Francesco Blasi Department Pathophysiology and Transplantation, University of Milan, Italy.
Discovery and development of antibiotics
EPID Introduction to Analysis and Interpretation of HIV/STD Data Confounding Manya Magnus, Ph.D. Summer 2001 adapted from M. O’Brien and P. Kissinger.
1 Modeling antibiotic resistance in populations: from deterministic to stochastic to agent-based models. Laura TEMIME G Thomas, PY Boëlle, D Guillemot.
Sensitivity Analysis for Observational Comparative Effectiveness Research Prepared for: Agency for Healthcare Research and Quality (AHRQ)
Topical oropharyngeal vancomycin to control methicillin resistant Staphylococcus aureus lower airway infection in ventilated patients L. Silvestry et al.
Chance, bias and confounding
2013 CLOSTRIDIUM DIFFICILE EDUCATIONAL AND CONSENSUS CONFERENCE March 11-12, 2013.
What is Mendelian Randomisation? Frank Dudbridge.
Epidemiology Kept Simple
FINAL REVIEW BIOST/EPI 536 December 14, Outline Before the midterm: Interpretation of model parameters (Cohort vs case-control studies) Hypothesis.
What intervention on the use or dosing of antibiotics work to decrease resistance? Jan. 18, 2007 Sung-Ching Pan.
What do case-control studies tell us about risk factors for antibiotic resistance? Christie Y. Jeon EPI502 Jan 22 nd, 2008.
Infection Control Friday 1/11/08. Spread of resistance Antibiotic pressure Human to human transmission.
Antibiotic Overuse – how much does it matter? Thursday 1/17/08.
Harvard University Initiative for Global Health Global Health Challenges Social Analysis 76: Lecture 17.
1 EPI235: Epi Methods in HSR March 31, 2005 L2 Evaluating Health Services using administrative data 1: Introduction to Risk Adjustment (Dr. Schneeweiss)
What ecological studies can & can’t tell us Justin O’Hagan 2 nd year Epi Doctoral Student.
Intermediate methods in observational epidemiology 2008 Confounding - I.
MRSA and VRE. MRSA  1974 – MRSA accounted for only 2% of total staph infections  1995 – MRSA accounted for 22% of total staph infections  2004 – MRSA.
Introduction to Molecular Epidemiology Jan Dorman, PhD University of Pittsburgh School of Nursing
MRSA and VRE. MRSA  1974 – MRSA accounted for only ____of total staph infections  1995 – MRSA accounted for _____ of total staph infections  2004 –
The role of drinking water as a source of transmission of antimicrobial resistant Escherichia coli Brenda L. Coleman, Allison McGeer, Marina Salvadori,
Statistical Issues in Data Collection and Study Design For Community Programs and Research October 11, 2001 Elizabeth Garrett Division of Biostatistics.
Factors Leading to the Spread of Vancomycin-Resistant Enterococci in US Hospitals Factors Antimicrobial pressure Environmental contamination and survival.
Epidemiology The Basics Only… Adapted with permission from a class presentation developed by Dr. Charles Lynch – University of Iowa, Iowa City.
TWO-STAGE CASE-CONTROL STUDIES USING EXPOSURE ESTIMATES FROM A GEOGRAPHICAL INFORMATION SYSTEM Jonas Björk 1 & Ulf Strömberg 2 1 Competence Center for.
Recommendation on prudent use of antimicrobial agents in human medicine – Slovenian experiences Intersectoral Coordination Mechanism Prof. Milan Čižman,
AETIOLOGY Case control studies (also RCT, cohort and ecological studies)
Designs to determine the impact of Ab resistance How do we correctly measure the outcomes of antibiotic resistance?
 Is there a comparison? ◦ Are the groups really comparable?  Are the differences being reported real? ◦ Are they worth reporting? ◦ How much confidence.
Amsterdam Rehabilitation Research Center | Reade Multiple regression analysis Analysis of confounding and effectmodification Martin van de Esch, PhD.
Antibacterial Drugs and the Risk of Community-Associated Methicillin-Resistant Staphylococcus aureus in Children Schneider-Lindner V, Quach C, Hanley JA,
Article Review Cara Carty 09-Mar-06. “Confounding by indication in non-experimental evaluation of vaccine effectiveness: the example of prevention of.
A short introduction to epidemiology Chapter 4: More complex study designs Neil Pearce Centre for Public Health Research Massey University Wellington,
1 EPIDEMIOLOGY 200B Methods II – Prediction and Validity Scott P. Layne, MD.
Analytical epidemiology Disease frequency Study design: cohorts & case control Choice of a reference group Biases Alain Moren, 2006 Impact Causality Effect.
Correlational Studies for Drug Effects Alec Walker October
11/20091 EPI 5240: Introduction to Epidemiology Confounding: concepts and general approaches November 9, 2009 Dr. N. Birkett, Department of Epidemiology.
Measuring Associations Between Exposure and Outcomes Chapter 3, Szklo and Nieto.
Low Cost Safety Improvements Pooled Funds Study Safety of Lane/Shoulder Width Combinations on Two-Lane Rural Roads Dr. Frank Gross, Vanasse Hangen Brustlin.
Matching. Objectives Discuss methods of matching Discuss advantages and disadvantages of matching Discuss applications of matching Confounding residual.
Design of Clinical Research Studies ASAP Session by: Robert McCarter, ScD Dir. Biostatistics and Informatics, CNMC
Matched Case-Control Study Duanping Liao, MD, Ph.D Phone:
Lab 8: Types of Studies and Study Designs Lab Workbook (pp. 37 – 40)
Transparency in the Use of Propensity Score Methods
MICROBIOLOGICAL EPIDEMIOLOGY OF RESPIRATORY SPECIMENS IN ICU PATIENTS Dr Farooq Cheema, Dr Waseem Tariq, Dr Raja Ishtiaq, Dr Tabassum Qureshi, Dr Vincent.
Moderate and Severe Obesity Have Large Differences in Health Care Costs Tatiana Andreyeva, RAND Graduate School Roland Sturm, RAND Jeanne S. Ringel, RAND.
KJO Hospital Infection Control Local 2176/2097 Ross Ibabao/ICCo.
Bringing Diversity into Impact Evaluation: Towards a Broadened View of Design and Methods for Impact Evaluation Sanjeev Sridharan.
Purpose of Epi Studies Discover factors associated with diseases, physical conditions and behaviors Identify the causal factors Show the efficacy of intervening.
MRSA: To isolate or not to isolate? Jean-François TIMSIT, MD PhD Medical ICU, University hospital Grenoble, France INSERM U 578 ESICM Barcelona – Sept.
Using Directed Acyclic Graphs (DAGs) to assess confounding Glenys Webster & Anne Harris May 14, 2007 St Paul’s Hospital Statistical “Rounds”
Vaccine Efficacy, Effectiveness and Impact
Randomized Trials: A Brief Overview
Presenter: Wen-Ching Lan Date: 2018/03/28
Risk of major congenital malformations among study infants according to fetal exposure to antihypertensives during first trimester alone* Variable ACE.
Figure 3 Potential interplay between physiological
Timeline of selected antibiotic development and reported resistance
Relative risk reduction for incident hypertension associated with weight loss of 6.8 kg: The Framingham Study Cohort Risk reduction (%) Relative risk.
Mendelian Randomization (Using genes to tell us about the environment)
E. Tacconelli  Clinical Microbiology and Infection 
Effect Modifiers.
Causation is defined by a different risk in the entire population under two potential exposure values; association is defined by a different risk in the.
Presentation transcript:

What can we learn from individual- level studies of antibiotic resistance? Molly Franke EPI 502 January 17, 2008

Outline Overview: individual-level studies Utility of individual-level studies Answerable questions Potential pitfalls / challenges Methicillin Resistant Staphylococcus Aureus

Individual Level Studies Cohort studies Case-control studies Cross-sectional studies  Time JanDec  Time JanDec

Utility of individual-level studies Directly link exposure and outcome Improved confounding control Step closer to causation (v. association) Individual effects 

Answerable Questions 1.Are there individual effects of antibiotic use on resistance? 2.Does individual effect of antibiotics differ by other variables? 3.Who is at highest risk for resistance? 4.When might interventions perform differently under different circumstances?

1. Individual effects Samore et al (Am J Epidemiol, 2006)

But… confounding? Analysis controlled for age, hh size, community, and year Unmeasured confounding? U CephalosporinCarriageCephalosporin

1. Individual effects Leibovici et al, J Antimicrob Chem 2001

2. Effects may differ by antibiotic Different antibiotic mechanisms Example: Strep pneumo carriage Cephalosporin, but not penicillin use associated with resistant carriage CephalosporinPenicillin Samore et al (Am J Epidemiol, 2006)

3. High risk groups Who should we target for interventions? Examples: Enteral feeding tubes VRE carriage Nonadherence increases TB resistance Interventions Altering feeding tube strategies DOT

4. Effect modification Interventions may work differently under different circumstances. Intervention modified by potential for transmission Example: VRE carriage (Bonten, Arch Intern Med 1998) At low colonization pressure, enteral tubes, antibiotic pressure predicted carriage When colonization pressure >50%, other variables had very little effect Bonten Arch Intern Med 1998

Another estimable quantity Samore, Am J Epidemiol, 2006 Exposure window

Potential pitfalls Independence assumptions –Example: Cox model Consider causal structure Colonization pressure: % of carriers in a pop. Hand washing Colonization pressure Carriage

Limitations Cost / Time Generalizeability Individual effect may vary by resistance levels Only half the story

Conclusions What can we learn from individual-level studies? INDIVIDUAL EFFECTS Expanded insight with: Multi-level models Mathematical modeling

THE END